Baker Bros. Advisors (GP) LLC, 10% Owner at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 1,749,137 shares at $8.63 ($14.3M) on 2018-01-17, disclosed to the SEC on 2018-01-19.
Open-market sale of $14.3M BLCM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.63 | 3,649 | $31K | 0.2% |
| 2 | $8.63 | 22,514 | $194K | 1.4% |
| 3 | $8.63 | 22,514 | $194K | 1.4% |
| 4 | $8.63 | 234,437 | $2.0M | 14.1% |
| 5 | $8.63 | 234,437 | $2.0M | 14.1% |
| 6 | $8.12 | 4,548 |
| $37K |
| 0.3% |
| 7 | $8.12 | 28,058 | $228K | 1.6% |
| 8 | $8.12 | 28,058 | $228K | 1.6% |
| 9 | $8.12 | 292,168 | $2.4M | 16.5% |
| 10 | $8.12 | 292,168 | $2.4M | 16.5% |
| 11 | $7.91 | 4,136 | $33K | 0.2% |
| 12 | $7.91 | 25,517 | $202K | 1.4% |
| 13 | $7.91 | 25,517 | $202K | 1.4% |
| 14 | $7.91 | 265,708 | $2.1M | 14.7% |
| 15 | $7.91 | 265,708 | $2.1M | 14.7% |
| Total | $8.20 avg | 1,749,137 | $14.3M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |